Published in J Neurol on September 01, 2002
Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology (1997) 1.64
The little imitator--porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry (1997) 1.14
Acute porphyric neuropathy during pregnancy--effect of haematin therapy. Eur Neurol (1998) 0.77
Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet Gynecol Scand (1997) 0.76
Acute porphyrias: diagnosis and management. Mayo Clin Proc (1994) 0.75
Acute peripheral neuropathy due to hereditary coproporphyria. Muscle Nerve (1994) 0.75
Porphyria with double errors in the heme biosynthetic pathway. J Neurol (2001) 0.75
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol (2012) 4.70
Chemotherapy-induced neuropathy. J Peripher Nerv Syst (2008) 2.97
Training of future interventional neuroradiologists: the European approach. Stroke (2012) 2.90
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol (2005) 1.55
Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol (2010) 1.49
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. Neuro Oncol (2009) 1.13
Progressive multifocal leukoencephalopathy after rituximab in a patient with relapsed follicular lymphoma and low IgG levels and a low CD4+ lymphocyte count. Leuk Lymphoma (2008) 1.06
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro Oncol (2013) 1.01
Peripheral nerve involvement in lymphoma: the meninges as the crucial barrier between meningoradicular spread and neurolymphomatosis. J Peripher Nerv Syst (2007) 0.99
Current approaches to the treatment of paraneoplastic encephalitis. Ther Adv Neurol Disord (2011) 0.99
[The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna]. Wien Klin Wochenschr (2002) 0.98
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping. Alcohol Alcohol (2004) 0.97
The end-of-life hospital setting in patients with glioblastoma. J Palliat Med (2008) 0.96
Myeloid sarcoma in the central nervous system: case report and review of the literature. Acta Clin Croat (2008) 0.94
Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neurooncol (2010) 0.92
Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary. Pathol Res Pract (2004) 0.91
The caregivers' perspective on the end-of-life phase of glioblastoma patients. J Neurooncol (2013) 0.91
Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kit. Gastroenterology (2012) 0.89
The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer (2013) 0.87
Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature. J Neurooncol (2012) 0.86
Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration. J Neurol Sci (2011) 0.86
Clinical core symptoms of posterior spinal artery ischemia. Eur Neurol (2011) 0.86
European Association of Young Neurologists and Trainees: position paper on teaching courses for Generation Y. Eur Neurol (2011) 0.84
Expiratory muscle weakness and assisted cough in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 0.82
Trigeminal neuralgia in two patients with glioblastoma. Headache (2005) 0.82
Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev (2012) 0.82
Hirayama disease in Austria. Joint Bone Spine (2012) 0.82
The influence of parotid gland sparing on radiation damages of dental hard tissues. Clin Oral Investig (2012) 0.81
Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis. Acta Myol (2011) 0.81
Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia. Transfusion (2011) 0.81
Alteration of serum thrombopoietin levels in patients with chronic hepatitis C under interferon therapy. Clin Hemorheol Microcirc (2010) 0.81
Exercise testing and training in German CF centers. Pediatr Pulmonol (2004) 0.80
Stroke in cancer patients: a risk factor analysis. J Neurooncol (2009) 0.80
Risks associated with exercise testing and sports participation in cystic fibrosis. J Cyst Fibros (2010) 0.80
Familial Creutzfeldt-Jakob disease initially presenting with alien hand syndrome. J Neurol (2002) 0.79
Secondary gliosarcoma with massive invasion of meninges, skull base, and soft tissue, and systemic metastasis. Clin Neuropathol (2013) 0.78
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun (2015) 0.78
Pyramidal tract degeneration in astrocytoma. J Neurooncol (2005) 0.78
Editorial: Brain tumour treatment: the concept of inter- and multidisciplinary treatment. Wien Med Wochenschr (2006) 0.77
FACS analysis-a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid. Clin Chim Acta (2002) 0.77
Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Hum Psychopharmacol (2000) 0.77
Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study. J Neurol (2014) 0.76
New type of cortical neuroplasticity after nerve repair in brachial plexus lesions. Arch Neurol (2011) 0.76
[Vitamin B12 deficiency. New data on an old theme]. Wien Klin Wochenschr (2005) 0.75
Comments on neurological aspects of taste disorders. Arch Neurol (2004) 0.75
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy. Int J Clin Pharmacol Ther (2014) 0.75
Serum antibodies against recoverin and Hu: two paraneoplastic epiphenomena in lung cancer. Lung Cancer (2005) 0.75
Antibiotic responsive demyelinating neuropathy related to Lyme disease. Neurology (2010) 0.75
Teaching the next generation of neurologists. Neurology (2009) 0.75
Response to letter regarding article, “training of future interventional neuroradiologists: the European approach. Stroke (2013) 0.75
Reversal of the proposed concept in ALS: are the cortical changes secondary? Muscle Nerve (2010) 0.75
Clinical neuropathology practice guide 1-2013: molecular subtyping of glioblastoma: ready for clinical use? Clin Neuropathol (2013) 0.75
Neurology training around the world: asking the trainees. Lancet Neurol (2010) 0.75
Neuromuscular symptoms in cancer patients. Expert Rev Neurother (2003) 0.75
Spinal cord involvement. Handb Clin Neurol (2012) 0.75
["Current aspects of stroke"]. Wien Med Wochenschr (2003) 0.75
Asymptomatic persistence of anti-Yo antibodies for 5 years without relapse of malignancy. Neuropathology (2007) 0.75
Anatomical and ultrasound correlation of the superficial branch of the radial nerve. Muscle Nerve (2014) 0.75
Electrophysiology and intraoperative neurophysiological monitoring. Handb Clin Neurol (2012) 0.75
Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy. J Peripher Nerv Syst (2009) 0.75
The global perspective on neurology training: the World Federation of Neurology survey. J Neurol Sci (2013) 0.75
Guidelines by the European Federation of Neurological Societies (EFNS) subcommittee for Continuing Medical Education (CME)--modification 2003. Eur J Neurol (2004) 0.75